Show simple item record

dc.contributor.advisorName Not Legibleen_US
dc.contributor.authorWalsh, Francis A.en_US
dc.date.accessioned2018-09-24T20:39:56Z
dc.date.available2018-09-24T20:39:56Z
dc.date.issued1952en_US
dc.identifier.urihttp://hdl.handle.net/10504/119312
dc.description.abstractPharmacological research has resulted in the development of new anticholinergic drugs. Clinical evaluation of these substances has judged them to be an improvement over older drugs in peptic ulcer management. The most prominent of the older therapeutic agents is atropine. | Using atropine as a standard, this paper will concern itself with an attempt to evaluate the action of newer preparations on both gastric secretion and motility in innervated and denervated pyloric pouch with gastric fistula dogs. | Studies by Benjamin, Roslere and Grossman (1) using Methanthellne bromide and atropine subcutaneously on histamine stimulated gastric pouches showed that both atropine and Methanthellne bromide inhibited gastric secretion. They report atropine to be approximately twenty times stronger than Methanthellne bromide in inhibiting gastric secretion to the same degree (this is based upon concentration of the drug used per kilogram of body weight).en_US
dc.language.isoen_USen_US
dc.publisherCreighton Universityen_US
dc.rightsA non-exclusive distribution right is granted to Creighton University and to ProQuest following the publishing model selected above.en_US
dc.titleObservation of the Inhibitory Effects on Gastric Secretion and Motility by Atropine-Like Agentsen_US
dc.typeThesis
dc.publisher.locationOmaha, Nebraskaen_US
dc.description.noteProQuest Traditional Publishing Optionen_US
dc.contributor.cuauthorWalsh, Francis A.en_US
dc.degree.levelMS (Master of Science)en_US
dc.degree.disciplinePharmacology (graduate program)en_US
dc.degree.nameM.S. in Pharmacologyen_US
dc.degree.grantorGraduate Schoolen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record